Epithalon vs Thymosin Alpha-1

Side-by-side comparison of Epithalon, Thymosin Alpha-1 — mechanism, dosing, half-life, side effects, and research status.

← Pick different peptides
Attribute Epithalon Epithalon (Epitalon) — Tetrapeptide Ala-Glu-Asp-Gly Longevity Thymosin Alpha-1 Thymosin Alpha-1 (Tα1) Longevity
Basics
Molecular type Synthetic TetrapeptideThymic Peptide
Amino acids 428
Molecular weight 390.3 Da3,108.4 Da
Half-life Short (hours)~2 hours
Route(s) Subcutaneous, IV, IntranasalSubcutaneous
Mechanism & Research
Primary mechanism Epithalon is the most studied peptide for telomere biology. Research demonstrates it activates telomerase (hTERT — the enzyme that extends telomeres) in human somatic cells, potentially reversing the telomere shortening … Thymosin Alpha-1 stimulates T-cell differentiation and maturation, particularly enhancing T-helper cell (Th1) responses. This drives improved cell-mediated immunity — the arm of the immune system responsible for clearing…
Research status Research Compound Research Compound
Evidence summary Epithalon has a unique research record — longitudinal human studies (20+ years) conducted primarily in Russia. While not meeting Western RCT standards, these studies provide an unusual depth of long-term human data for a… Thymosin Alpha-1 has extensive human clinical data from its regulatory approval in Asia and Europe for viral hepatitis and cancer adjunct therapy. Longevity applications build on this established safety and immune-modula…
Protocol & Dosing
Typical dose 5–10 mg per day1.6 mg per injection (standard clinical dose)
Frequency Once daily (for 10-day course)2x per week for 6–12 weeks
Duration 10-day course, 2x per year6–12 weeks
Timing Any time; typically morningAny time of day
Safety
Common side effects
  • Injection site redness
  • Mild fatigue (first few days)
  • Vivid dreams (pineal modulation)
  • Injection site redness
  • Mild flu-like symptoms (first injection)
  • Fatigue (transient)
Contraindications
  • Active malignancy (telomerase activation in cancer cells is theoretical concern)
  • Autoimmune conditions (caution)
  • Pregnancy (no data)
  • Active autoimmune disease (immune stimulation risk)
  • Post-organ transplant (immunosuppression may be reversed)
  • Known allergy to thymic peptides
Anti-doping Not Prohibited Not Prohibited
Deeper reading
Related peptides Thymosin Alpha-1, GHK-Cu, MOTS-c, Humanin Epithalon, TB-500, LL-37
Full profile Read full Epithalon profile → Read full Thymosin Alpha-1 profile →

Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.